Compare Expensify Inc (EXFY) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expensify Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Expensify Inc trades at $2.3 (market cap $208.82M), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 18.3× Expensify Inc's market cap, and Expensify Inc is more actively traded (456,102 versus 4,332,079). Which is the better fit depends on your goals — on Pluang, investors hold Expensify Inc for 41 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| EXFY | RLAY | |
|---|---|---|
Market Cap | $208.82M | $3.82B |
Volume | 456,102 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $2.72 | $20.75 |
52-Week Low | $0.75 | $6.03 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | $148.44M | $2.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Expensify (EXFY) trades at $2.27, up 1.79% with a neutral technical signal. The company shows mixed fundamentals with revenue stabilizing around $140M but persistent net losses. Recent quarters show earnings improvement with two beats, while analyst consensus is bullish with a $13.75 price target. Business developments include AI integrations and European expansion of corporate card offerings.
The outlook remains speculative given negative profitability metrics, though cash flow improvements and strategic partnerships provide potential catalysts. Key risks include competitive pressure in expense management and the challenge of achieving sustainable profitability. The significant gap between current price and analyst targets suggests upside potential if execution improves.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Expensify Inc
Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.
Read more on EXFY →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
